Combining non-depolarizing neuromuscular blocking agents: Synergism, addition or antagonism?

Current Opinion in Anaesthesiology

Volumn 12, Issue 4, 1999, Pages 467-471

  Lien, Cynthia A ^a,b  

^a New York Presbyterian Hosiptal ^*  (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; CISATRACURIUM; DIMETHYLTUBOCURARINE CHLORIDE; DOXACURIUM; MIVACURIUM; MUSCARINIC RECEPTOR; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; PIPECURONIUM; ROCURONIUM; TUBOCURARINE CHLORIDE; VECURONIUM;

CARDIOVASCULAR DISEASE; DRUG STRUCTURE; GENERAL ANESTHESIA; HUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0032748040     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-199908000-00013     Document Type: Short Survey

References (30)

1. Schou J, Ginz HF. Interaction of non-depolarizing muscular relaxants is potentially useful. Acta Anaesthesiol Scand 1997; 41:87-88.
2. Wangler MD, Thapar P, Skerman JH. Decreased mivacurium constant infusion requirements with defasiculating doses of pancuronium. Anesth Analg 1997; 84:668-671.
3. Rautoma P, Erkola O, Meretoja OA. Potency and hourly maintenance requirement of combinations of mivacurium and pancuronium in adults. Can J Anaesth 1998; 45:212-216. Combinations of mivacurium and pancuronium were shown to be more potent than either relaxant alone. Maintenance of twitch suppression with the combination of relaxants decreased the amount of relaxants used.
4. Lebowitz PW, Ramsey FM, Savarese JJ, Ali HH, Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine. Anesth Analg 1980; 59:604-609.
5. Lebowitz PW, Ramsey FM. Savarese JJ, Ali HH, De Bros FM. Combination of pancuronium and metocurine: neuromuscular and hemodynamic advantages over pancuronium alone. Anesth Analg 1981; 60:12-18.
6. Waud BE, Waud DR. Interaction among agents that block end-plate depolarization competitively. Anesthesiology 1985; 63:4-15.
7. Bowman WC, Marshall IG, Gibb AJ. Is there feedback control of transmitter release at the neuromuscular junction? Semin Anesth 1984; 3:275-283.
8. Bowman WC, Gibb AJ, Harvey AL, Marshall IG. Prejunctional actions of cholinoceptor agonists and antagonists and of anticholinesterase drugs. In: New neuromuscular blocking agents, handbook of experimental pharmacology, Vol. 79. Kharkevich DA (editor). Berlin: Springer Verlag: 1986.
9. Bowman WC, Marshall IG, Gibb AJ, Harborne AJ. Feedback control of transmitter release at the neuromuscular junction. Trends Pharmacol Sci 1988; 9:16-20.
10. Bowman WC. Pharmacology of neuromuscular function, 2nd ed. London: Wright: 1990.
11. Naguib M, Abdulatif M, al-Ghamdi A, Selim M, Seraj M, el-Sanbary M, Magboul MA. Interactions between mivacurium and atracurium. Br J Anaesth 1994; 73:484-489.
12. Boros EE, Bigham EC, Boswell GE, Mook RA, Patel SS, Savarese JJ, et al. Bis-and mixed-tetrahydroisoquinolinium chlorofumarates: new ultra-short-acting nondepolarizing neuromuscular blockers. J Med Chem 1999; 42:206-209. This is a description of the development of a new non-depolarizing neuromuscular blocker with a unique chemical structure.
13. Black TE, Healy TE, Pugh ND, Kay B, Harper NJ, Petts HV, Sivalingham T. Neuromuscular block: atracurium and vecuronium compared and combined. Eur J Anesthesiol 1985; 2:29-37.
14. Meretoja QA, Brandom BW, Taivainen T, Jalkanen. Synergism between atracurium and vecuronium in children. Br J Anaesth 1993; 71:440-442.
15. Van Der Speck AFL, Zupan JT, Pollard BJ, Schork MA. Interactions of vecuronium and atracurium in an in vitro nerve-muscle preparation. Anesth Analg 1988; 67:240-246.
16. Gibbs NM, Rung GW, Braunegg PW, Martin DE. The onset and duration of neuromuscular blockade using combinations of atracurium and vecuronium. Anaesth Intens Care 1991; 19:96-100.
17. 95 dose of the relaxants was administered were compared. The authors found that vecuronium had a slower onset and a shorter duration of action than either atracurium or the combination of drugs.
18. M, Samarkandi AH, Ammar A, Al-Zahrani S, Comparative clinical pharmacology of rocuronium, cisatracurium, and their combination. Anesthesiology 1998; 89:1116-1124. In this three-part study the authors determined the dose-response relationships for cisatracurium and rocuronium, the time course of four doses of each of the relaxants administered alone and the dose response curves for a combination of the two relaxants. They found that the combination of the relaxants behaved synergistically.
19. Feldman SA, Fauvel NJ, Hood JR. Recovery from pancuronium and vecuronium administered simultaneously in the isolated forearm and the effect on recovery following administration after cross-over of drugs. Anesth Analg 1993; 76:92-95.
20. Jalkanen L, Rautoma P, Taivainen T, Meretoja OA. The pharmacodynamics of mivacurium preceded by atracurium or cisatracurium in children. Anesth Analg 1998; 86:62-65. Mivacurium administered after 25% recovery following mivacurium, cisatracurium or atracurium-induced neuromuscular block. Recovery in the patients receiving cisatracurium or atracurium was significantly prolonged when compared with the patients who had received only mivacurium. As no dose response studies were done we cannot determine whether or not these relaxants behave synergistically.
21. Jaikanen L, Meretoja OA, Taivainen T, Brandom BW, Dayal B. Synergism between atracurium and mivacurium compared with that between vecuronium and mivacurium. Anesth Analg 1994; 79:998-1002.
22. Goudsouzian N, Martyn JA. Potentiation of mivacurium by rocuronium is age-and time-dependent: a study in children, adolescents, and young and elderly adults. J Clin Pharmacol 1997; 37:649-655.
23. Lien CA, Schmith VD, Embree PB, Belmont MR, Wargin WA, Savarese JJ. The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/optoid/barbiturate anesthesia. Anesthesiology 1094; 80:1296-1302.
24. Stovner J, Oftedal N, Holmboe J. The inhibition of cholinesterases by pancuronium. Br J Anaesth 1975; 47:949-954.
25. Popovic L, Kunec-Vajic E. Inhibition of plasma cholinesterase by pancuronium and vecuronium. Lilec Vjesn 1990; 115:142-143.
26. Brandom BW, Meretoja OA, Taivainen T, Wirtavouri K. Accelerated onset and delayed recovery of neuromuscular block induced by mivacurium preceded by pancuronium in children. Anesth Analg 1993; 76:998-1003.
27. Rautoma P, Erkola O, Meretoja OA. Synergism between mivacurium and pancuronium in adults, Acta Anaesthesiol Scand 1995; 39:733-737.
28. Erkola O, Rautoma P, Meretoja OA. Mivacurium when preceded by pancuronium becomes a long-acting muscle relaxant. Anesthesiology 1996; 84:562-565.
29. Kim KS, Shim JC, Kim DW. Interactions between mivacurium and pancuronium. Br J Anaesth 1997; 79:19-23.
30. Beaussier M, Deriaz H, De Traverse A, Abdelhalim Z, Lienhart A. Duration of the pharmacodynamic interaction between pancuronium and mivacurium. Br J Anaesth 1998; 81:251-252. In this study, patients received repeated 0.04 mg/kg mivacurium after recovery to a post-tetanic count of 10 after pancuronium-induced neuromuscular block. The duration of action of mivacurium was prolonged to more than 2 h after the final pancuronium dose.